The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • Despite there being a valid 'cspec' property in the messages there's a discrepancy in message contents and CSPEC data: * Message Gene: ATM CSPEC Genes: [ 'ATM' ] * Message MONDOs: MONDO:0700270 CSPEC MONDO: [ 'MONDO:0016419', 'MONDO:0008840', 'MONDO:0018266' ]
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000051.4(ATM):c.5005+1G>T

CA16041413

371636 (ClinVar)

Gene: ATM
Condition: ATM-related cancer predisposition
Inheritance Mode: Autosomal dominant inheritance
UUID: f2c45aa0-d48d-42cc-897e-3103827a3330
Approved on: 2024-11-26
Published on: 2025-01-13

HGVS expressions

NM_000051.4:c.5005+1G>T
NM_000051.4(ATM):c.5005+1G>T
NC_000011.10:g.108297383G>T
CM000673.2:g.108297383G>T
NC_000011.9:g.108168110G>T
CM000673.1:g.108168110G>T
NC_000011.8:g.107673320G>T
NG_009830.1:g.79552G>T
ENST00000452508.7:c.5005+1G>T
ENST00000713593.1:c.*4476+1G>T
ENST00000278616.9:c.5005+1G>T
ENST00000683174.1:n.6489+1G>T
ENST00000683524.1:n.229+1G>T
ENST00000684152.1:n.719+1G>T
ENST00000527805.6:c.*69+1G>T
ENST00000675595.1:c.*69+1G>T
ENST00000675843.1:c.5005+1G>T
ENST00000278616.8:c.5005+1G>T
ENST00000452508.6:c.5005+1G>T
ENST00000524792.5:n.1220+1G>T
ENST00000533690.5:n.409+1G>T
NM_000051.3:c.5005+1G>T
NM_001351834.1:c.5005+1G>T
NM_001351834.2:c.5005+1G>T
More

Likely Pathogenic

Met criteria codes 3
PVS1_Strong PM2_Supporting PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hereditary Breast, Ovarian and Pancreatic Cancer Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ATM Version 1.3.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hereditary Breast, Ovarian and Pancreatic Cancer VCEP
The c.5005+1G>T variant in ATM occurs within the canonical splice donor site (+1,2) of intron 33. It is predicted to cause skipping of a biologically-relevant-exon, resulting in an in-frame deletion that is predicted to escape nonsense mediated decay. This variant has been detected in at least 1 individual with Ataxia-Telangiectasia (PMID: 26896183). This variant is absent from gnomAD v2.1.1. In summary, this variant meets criteria to be classified as likely pathogenic for autosomal dominant ATM-related cancer predisposition and autosomal recessive Ataxia-Telangiectasia based on the ACMG/AMP criteria applied, as specified by the HBOP Variant Curation Expert Panel. (PVS1_Strong, PM3, PM2_Supporting)
Met criteria codes
PVS1_Strong
The c.5005+1G>T variant in ATM occurs within the canonical splice donor site (+/- 1,2) of intron 33. It is predicted to cause skipping of biologically-relevant-exon 33, resulting in an in-frame deletion that is predicted to escape nonsense mediated decay (PVS1_Strong).
PM2_Supporting
This variant is absent from gnomAD v2.1.1
PM3
This variant has been detected in 1 individual with ataxia-telangiectasia (PMID:26896183, PM3_Moderate).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.